Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovative Pharmaceutical Biotech
Wan Chai, Hong Kong
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Innovative Pharmaceutical Biotech focuses on the research and development of an orally administered insulin product targeting diabetes. The company also operates in genetic testing services, healthcare management, distribution of bio-industrial products, and trading beauty equipment/products. There are no reported clinical results or approved drugs as of the latest available information.
- Therapeutic areas
- Endocrinology
- Modalities
- Small moleculeRecombinant proteinGenetic testing servicesBio-industrial products
- Industry
- Biotech
Beyond the preview
Go deeper on Innovative Pharmaceutical Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Innovative Pharmaceutical Biotech.